The TF expression has been previously reported in endometrial endometrioid adenocarcinoma cell lines (i.e., the most common and less aggressive variant of human endometrial cancer; Kato et al, 2005, 2008). Here, TF is linked to endometrial endometrioid adenocarcinoma.